LOS ANGELES (Reuters) - The largest U.S. manager of prescription benefits is telling drugmakers that the current pricing model is broken, and taking aim at Amgen Inc and other makers of new migraine medicines to try and fix it.

Topics:  los angeles reuters     the   u.s    amgen inc   migraine   pricing   
BING NEWS:
  • Express Scripts targets Amgen, Lilly migraine drugs in pricing shift
    The largest U.S. manager of prescription benefits is telling drugmakers that the current pricing model is broken, and taking aim at Amgen Inc, Eli Lilly and Co and other makers of new migraine medicin...
    04/25/2018 - 3:41 am | View Link
  • Express Scripts targets Amgen, Lilly migraine drugs in pricing shift
    LOS ANGELES (Reuters) - The largest U.S. manager of prescription ... adopting similar tactics to Express Scripts in negotiating coverage for the migraine drugs. CVS declined comment. Teva said it was ...
    04/24/2018 - 2:27 pm | View Link
  • Express Scripts targets new migraine drugs to change U.S. pricing dynamic
    LOS ANGELES • The largest U.S. manager of prescription benefits is telling drugmakers that the current pricing model is broken, and taking aim at Amgen Inc. and other makers of new migraine medicines ...
    04/24/2018 - 12:21 pm | View Link
  • A massive pharmaceutical middleman is taking aim at the price of a new group of migraine drugs
    It also wants a refund if the drugs ... U.S. manager of prescription benefits is telling drugmakers that the current pricing model is broken, and taking aim at Amgen Inc and other makers of new migrai...
    04/24/2018 - 10:47 am | View Link
  • Express Scripts targets Amgen, Lilly migraine drugs in pricing shift
    LOS ANGELES (Reuters) - The largest U.S. manager of prescription benefits is telling drugmakers that the current pricing ... Express Scripts is advising drugmakers to take that shift into account as t...
    04/24/2018 - 6:30 am | View Link
  • More
BING SEARCH:
  • Drug Channels: Drug Channels News Roundup, April 2018 ...
    Well, pierce my ears and call my drafty. Apparently, Express Scripts is pressing manufacturers of new migraine drugs to “to forego the usual strategy of setting a high U.S. list price, then lowering the cost for health plans through hefty rebates.”
    07/14/2018 - 6:04 am | View Website
  • Business News, Personal Finance and Money News
    Find the latest business news on Wall Street, jobs and the economy, the housing market, personal finance and money investments and much more on ABC News
    07/14/2018 - 12:56 am | View Website
  • ESRX Stock Price
    Express Scripts Holding Co. stock price, stock quotes and financial overviews from MarketWatch.
    07/13/2018 - 5:08 am | View Website
  • Wires
    2 Mins Ago. July 11- U.S. stocks were set to open lower on Wednesday, halting a four-day run of gains after the United States threatened to impose tariffs on an additional $200 billion worth of Chinese goods, dampening hopes of a compromise on trade.
    07/13/2018 - 5:08 am | View Website
  • AFSPA
    Braftovi and Mektovi Approved to Treat Melanoma. On June 27, 2018, the U.S. Food and Drug Administration (FDA) approved Array BioPharma’s two new drugs, Braftovi™ (encorafenib) capsules and Mektovi® (binimetinib) tablets.
    07/11/2018 - 12:34 pm | View Website
  • More
Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More U.s. News